Stocks and Investing
Stocks and Investing
Thu, March 31, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Michael Ng Maintained (BLND) at Strong Buy with Decreased Target to $9 on, Mar 31st, 2022
Michael Ng of Goldman Sachs, Maintained "Blend Labs, Inc." (BLND) at Strong Buy with Decreased Target from $23 to $9 on, Mar 31st, 2022.
Michael has made no other calls on BLND in the last 4 months.
There are 5 other peers that have a rating on BLND. Out of the 5 peers that are also analyzing BLND, 2 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Terry Tillman of "Truist Securities" Downgraded from Strong Buy to Hold and Held Target at $7.5 on, Monday, March 21st, 2022
- Ryan Tomasello of "Keefe, Bruyette & Woods" Initiated at Hold and Held Target at $12 on, Monday, February 14th, 2022
These are the ratings of the 3 analyists that currently disagree with Michael
- Michael Turrin of "Wells Fargo" Maintained at Buy with Decreased Target to $11 on, Tuesday, March 15th, 2022
- Josh Beck of "Keybanc" Maintained at Buy with Decreased Target to $10 on, Tuesday, January 25th, 2022
- Arvind Ramnani of "Piper Sandler" Maintained at Buy with Decreased Target to $10 on, Thursday, January 13th, 2022
Contributing Sources